[GC Genome Listing③] Overlapping Listings Among GC Group Affiliates Raise Concerns Over Shareholder Value

GC Genome’s IPO highlights concerns over overlapping listings within GC Group, raising fears of shareholder value dilution and renewed scrutiny of the “Korea Discount.”